Search
Matt Callahan said the product received an excellent safety profile.

Botanix up on study results

Shares in medical dermatology company Botanix Pharmaceuticals, led by Perth-based chairman Graham Griffiths and executive director Matt Callahan, have jumped more than 20 per cent today after the company announced successful results from an acne patient study.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/12/19

1 year TSR5 year TSR
271stBotanix Pharmaceuticals21%42%
424thBauMart Holdings-2%
541stHotCopper Holdings-19%
691stNuheara-48%24%
668 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

11/12/19
$27k Other
18/07/19
$0 Issued
27/04/18
$19k Bought
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

93rd↑Botanix Pharmaceuticals$4.7m
94th↑BauMart Holdings$4.6m
95th↑Nuheara$4.5m
97th↑HotCopper Holdings$4.3m
98th↑Sterling Plantations$4.2m
197 listed industrial companies ranked by revenue.
Powered by Morningstar ®